FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,193 | -52.2% | 17,336 | -43.8% | 0.00% | – |
| Q2 2023 | $272,247 | +57.7% | 30,832 | +48.6% | 0.00% | – |
| Q1 2023 | $172,648 | -14.3% | 20,751 | -1.1% | 0.00% | – |
| Q4 2022 | $201,456 | +259.7% | 20,985 | +109.2% | 0.00% | – |
| Q2 2022 | $56,000 | -23.3% | 10,029 | -23.3% | 0.00% | – |
| Q1 2022 | $73,000 | +23.7% | 13,080 | -2.7% | 0.00% | – |
| Q4 2021 | $59,000 | -53.5% | 13,448 | +0.1% | 0.00% | – |
| Q3 2021 | $127,000 | +29.6% | 13,432 | +0.3% | 0.00% | – |
| Q2 2021 | $98,000 | -25.2% | 13,398 | -36.4% | 0.00% | – |
| Q1 2021 | $131,000 | -28.8% | 21,057 | -14.6% | 0.00% | – |
| Q4 2020 | $184,000 | +22.7% | 24,671 | -0.5% | 0.00% | – |
| Q3 2020 | $150,000 | -41.2% | 24,800 | -18.9% | 0.00% | – |
| Q2 2020 | $255,000 | +203.6% | 30,561 | +114.9% | 0.00% | – |
| Q1 2020 | $84,000 | -8.7% | 14,224 | 0.0% | 0.00% | – |
| Q4 2019 | $92,000 | +7.0% | 14,224 | +36.3% | 0.00% | – |
| Q3 2018 | $86,000 | -51.4% | 10,438 | -38.6% | 0.00% | – |
| Q2 2018 | $177,000 | -18.8% | 16,990 | -5.6% | 0.00% | – |
| Q1 2018 | $218,000 | – | 17,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |